Abstract
Corynebacterium urealyticum has been well documented as a urinary pathogen in Europe. The purpose of this study was to investigate the incidence and clinical relevance ofCorynebacterium urealyticum as a urinary pathogen in a predominantly Third World population (South Africa) and to attempt to increase the isolation rate by culturing urine specimens on a selective medium. Two methods were used to isolateCorynebacterium urealyticum from urine specimens. Blood agar plates from routine urine cultures of 7,912 urine specimens were incubated for 48 hours and 1,281 specimens were cultured on a selective medium as well as on routine media. The antimicrobial susceptibility of all isolates ofCorynebacterium urealyticum was tested. The yield ofCorynebacterium urealyticum on blood agar was three isolates in three patients (0.038% of 7,912), all of whom had pyuria, alkaline urine and risk factors forCorynebacterium urealyticum infection. Use of selective media increased the yield ofCorynebacterium urealyticum to 15 of 1,281 specimens (1.17%), however 73% of these urine samples yielded other pathogens and none had an alkaline pH which could not be attributed to the presence of another urealytic pathogen. All isolates were susceptible to vancomycin and 92.6% susceptible to norfloxacin. The pathogenic potential ofCorynebacterium urealyticum was confirmed in South African patients, but the incidence of infection was low. The use of a selective medium is therefore not cost-effective in all cases but could be used selectively on the basis of typical urine findings and patient criteria.
Similar content being viewed by others
References
Aguado JM, Ponte C, Soriano F Bacteriuria with a multiply resistant species ofCorynebacterium (Corynebacterium group D2): an unnoticed case of urinary tract infection. Journal of Infectious Diseases 1987, 156: 144–150.
Soriano F, Aguado J, Ponte C, Fernandez-Roblas R, Rodriguez-Tudela J Urinary tract infection caused byCorynebacterium group D2: report of 82 cases and review. Reviews of Infectious Diseases 1990, 12: 1019–1034.
Soriano F, Fernandez-Roblas R Infections caused by antibiotic resistantCorynebacterium group D2. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 337–341.
Soriano F, Ponte C, Santamaria M, Aguado JM, Wilhelmi I, Vela R, Cifuentes Delatte L Corynebacterium group D2 as a cause of alkaline encrusted cystitis: report of four cases and characterization of the organisms. Journal of Clinical Microbiology 1985, 21: 788–792.
Marty N, Clave D, Cancet B, Henry-Ferry S, Didier J Corynebacterium groupe D2. Etude clinique, identification biochimique et sensibilité aux antibiotiques. Pathologie Biologie 1988, 36: 460–464.
Fosse T, Carles D, Laffont C, Lefebvre J, Bocquet J Infections urinairesCorynebacterium du groupe D2. Epidemie hospitalière et sensibilité aux antibiotiques. Pathologie Biologie 1988, 36: 742–745.
De Briel D, Langs JC, Rougeron G, Chabot P, Le Faou A Multiresistant corynebacteria in bacteriuria: a comparative study of the role ofCorynebacterium group D2 andCorynebacterium jeikeium. Journal of Hospital Infection 1991, 17: 35–43.
Wichmann S, Wirsing von Koenig CH, Becker-Boost E, Finger H Isolation ofCorynebacterium group JK from clinical specimens with a semiselective medium. Journal of Clinical Microbiology 1984, 19: 204–206.
Soriano F, Rodriguez-Tudela J, Fernandez-Roblas R, Aguado J, Santamaria M Skin colonization byCorynebacterium groups D2 and JK in hospitalised patients. Journal of Clinical Microbiology 1988, 26: 1878–1880.
Coyle MB, Lipsky BA Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clinical Microbiology Reviews 1990, 3: 227–246.
National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disc susceptibility tests. 4th edition. Approved standard M2-A4. NCCLS, Villanova, PA, 1990.
Fernandez-Roblas R, Prieto S, Santamaria M, Ponte C, Soriano F Activity of nine antimicrobial agents againstCorynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrobial Agents and Chemotherapy 1987, 31: 821–822.
Garcia-Rodriguez JA, Garcia Sanchez JE, Munoz Bellido JL, Nebreda Mayoral T, Garcia Sanchez E, Garcia Garcia I In vitro activity of 79 antimicrobial agents againstCorynebacterium group D2. Antimicrobial Agents and Chemotherapy 1991, 35: 2140–2143.
Philippon A, Bimet F In vitro susceptibility ofCorynebacterium group D2 andCorynebacterium jeikeium to twelve antibiotics. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 892–895.
Santamaria M, Ponte C, Wilhelmi I, Soriano F Antimicrobial susceptibility ofCorynebacterium group D2. Antimicrobial Agents and Chemotherapy 1985, 28: 845–846.
Soriano F, Ponte C, Santamaria M, Torres A, Fernandez-Roblas R Susceptibility of urinary isolates ofCorynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid. Journal of Antimicrobial Chemotherapy 1987, 20: 349–355.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walkden, D., Klugman, K.P., Vally, S. et al. Urinary tract infection withCorynebacterium urealyticum in South Africa. Eur. J. Clin. Microbiol. Infect. Dis. 12, 18–24 (1993). https://doi.org/10.1007/BF01997051
Issue Date:
DOI: https://doi.org/10.1007/BF01997051